Acalabrutinib in Patients (pts) with Waldenstrom Macroglobulinemia (WM)

Roger Owen, Helen McCarthy, Simon Rule, Shirley D'Sa, Sheeba Thomas, Francesco Forconi, Thomas Anderson, Marie Jose Kersten, Pier Luigi Zinzani, Sunil Iyengar, Jaimal Kothari, Monique Minnema, Efstathios Kastritis, Raquel Izumi, J. Greg Slatter, Diana Mittag, Helen Wei, Dih-Yin Chen, Priti Patel, Richard R. Furman

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S285-S286
JournalClinical Lymphoma, Myeloma and Leukemia
Volume18
Publication statusPublished - Sept 2018

Keywords

  • Waldenström macroglobulinemia
  • acalabrutinib
  • relapsed
  • refractory
  • treatment-naïve
  • BTK inhibitor

Cite this